Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension Stage 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01523067
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

Who this might be right for
Essential Hypertension
PhaseBio Pharmaceuticals Inc. 68
Early research (Phase 1)Looking for participantsNCT05967299
What this trial is testing

Study of Intravenous ZMA001 in Healthy Subjects

Who this might be right for
Pulmonary Arterial Hypertension PAH
National Heart, Lung, and Blood Institute (NHLBI) 96
Post-approval studies (Phase 4)UnknownNCT03592667
What this trial is testing

Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

Who this might be right for
Hypertension
University of Guadalajara 20
Early research (Phase 1)Study completedNCT04688632
What this trial is testing

Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects

Who this might be right for
Symptomatic Neurogenic Orthostatic HypertensionnOH
Theravance Biopharma 72
Testing effectiveness (Phase 2)Study completedNCT00753168
What this trial is testing

Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Othera Pharmaceuticals 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675824
What this trial is testing

REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Regeneron Pharmaceuticals 271
Large-scale testing (Phase 3)Enrolling By InvitationNCT03683186
What this trial is testing

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 1,000
Testing effectiveness (Phase 2)Study completedNCT05822245
What this trial is testing

PER-001 in Participants With Open-Angle Glaucoma

Who this might be right for
Open-angle Glaucoma
Perfuse Therapeutics, Inc. 33
Early research (Phase 1)Study completedNCT05966324
What this trial is testing

Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population

Who this might be right for
Hypertension
AstraZeneca 41
Not applicableUnknownNCT05899920
What this trial is testing

Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy

Who this might be right for
Resistant Arterial Hypertension
Ryazan State Medical University 190
Not applicableStudy completedNCT05158569
What this trial is testing

Comparison of Breathing Exercise for Hypertensive Patients

Who this might be right for
Hypertension
Riphah International University 32
Not applicableNot Yet RecruitingNCT07475208
What this trial is testing

NR and Exercise for Blood Pressure

Who this might be right for
Hypertension (HTN)
ZHANG Jiaqi 112
Not applicableStudy completedNCT01258764
What this trial is testing

Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril

Who this might be right for
Hypertension, Grade 1Hypertension TreatmentN of 1 Study Design+1 more
Scripps Translational Science Institute 2
Testing effectiveness (Phase 2)Study completedNCT02944734
What this trial is testing

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Shin Poong Pharmaceutical Co. Ltd. 392
Not applicableStudy completedNCT04364984
What this trial is testing

ARB, ACEi, DRi Effects on COVID-19 Course Disease

Who this might be right for
HypertensionCOVID-19
Medical Practice Prof D. Ivanov 112
Early research (Phase 1)Study completedNCT01246193
What this trial is testing

CKD-828(80/2.5mg) Pharmacokinetic Study

Who this might be right for
Hypertension
Chong Kun Dang Pharmaceutical 65
Not applicableUnknownNCT02480517
What this trial is testing

Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension

Who this might be right for
Hypertension
Kona Medical Inc. 60
Early research (Phase 1)Study completedNCT04200573
What this trial is testing

Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855

Who this might be right for
Symptomatic Neurogenic Orthostatic HypertensionnOH
Theravance Biopharma 31
Early research (Phase 1)Study completedNCT03934307
What this trial is testing

Evaluate ALN-AGT01 in Patients With Hypertension

Who this might be right for
Hypertension
Alnylam Pharmaceuticals 124
Post-approval studies (Phase 4)Study completedNCT00351130
What this trial is testing

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Who this might be right for
Hypertension
Novartis 79
Next Page